The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

In the latest round of litigation surrounding the controversial drug Vioxx, jurors in New Jersey heard opening statements from both sides today in what could be the most pivotal Vioxx trial yet. Merck, the former producer of Vioxx, has received two defense verdicts involving the pain killer to date but lost a third trial that resulted in a $253 million dollar jury verdict for the widow of a Wal-Mart employee who died from a heart attack while taking Vioxx

According to the

Mark Lanier, the attorney for Thomas Cona, 59, said the use of Vioxx made people with risk factors for heart disease “walking time bombs” but Merck withheld information about the drug to make more money selling it.

“They decided to cut corners. That’s basically what this case is about,” Lanier said in opening statements


Read More About The New Jersey Vioxx Trial

Comments for this article are closed.